Literature DB >> 7782902

Primary chylomicronemia in patients with severe familial hypertriglyceridemia responds to long-term treatment with (n-3) fatty acids.

V Pschierer1, W O Richter, P Schwandt.   

Abstract

Because it disturbs microcirculation, chylomicronemia can cause severe clinical complications such as acute pancreatitis. Dietary measures are very important in the prevention and treatment of this condition. Dietary supplementation with (n-3) fatty acids has been shown to be of benefit in short-term treatment of chylomicronemia. To evaluate the long-term efficacy of (n-3) fatty acids we added 2.16 or 4.32 g/d (for 3 mo) and 3.24 g/d (for a further 8 mo after 1 mo of no treatment) (n-3) fatty acids to the diet of eight patients with primary chylomicronemia. Serum triglycerides decreased significantly from 15.0 +/- 2.5 to 9.9 +/- 2.8 mmol/L (P < 0.01) after 11 mo of treatment, and VLDL triglycerides decreased from 12.3 +/- 2.8 to 9.0 +/- 2.4 mmol/L (P < 0.01), resulting in a significant decrease of plasma viscosity from 1.56 +/- 0.17 mPa-s to 1.47 +/- 0.12 mPa.s (P < 0.01). Total cholesterol, HDL and LDL cholesterol as well as lipoprotein (a) and fibrinogen concentrations were not affected by fish oil treatment. The presence of chylomicrons and chylomicron remnants (apolipoprotein B 48 concentration in the lipoprotein fraction with a density lower than 1.006 kg/L) was significantly reduced from 4.82 +/- 1.08 to 1.06 +/- 0.38 mg/L (P < 0.01). Body weight increased significantly from 71.0 +/- 4.6 kg to 75.2 +/- 5.3 kg after 11 mo of treatment with (n-3) fatty acids.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782902     DOI: 10.1093/jn/125.6.1490

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  4 in total

Review 1.  Omega-3 fatty acids: their beneficial role in cardiovascular health.

Authors:  Gerry Schwalfenberg
Journal:  Can Fam Physician       Date:  2006-06       Impact factor: 3.275

Review 2.  Chylomicronaemia--current diagnosis and future therapies.

Authors:  Amanda J Brahm; Robert A Hegele
Journal:  Nat Rev Endocrinol       Date:  2015-03-03       Impact factor: 43.330

3.  Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis.

Authors:  O Helk; R Schreiber; K Widhalm
Journal:  Eur J Clin Nutr       Date:  2016-05-18       Impact factor: 4.016

4.  Hypertriglyceridemia and Recurrent Pancreatitis following Splenectomy.

Authors:  Michael Butman; David Taylor; Kristina Boström; Manuel Quinones; Susanne B Nicholas
Journal:  Case Rep Gastroenterol       Date:  2007-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.